SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PE Biosystems (PEB) -- Ignore unavailable to you. Want to Upgrade?


To: PuddleGlum who wrote (10)1/22/1998 1:41:00 AM
From: fut_trade  Respond to of 122
 
S-3 filed yesterday.

freeedgar.com

Peter

THE MERGER

Pursuant to the Merger Agreement, on January 22, 1998, Merger Sub was merged
with and into PerSeptive, and each outstanding share of PerSeptive Common Stock
was converted into 0.1926 of a share of Common Stock. As a result of the Merger,
PerSeptive became a wholly-owned subsidiary of the Company. The Merger is being
treated as a "pooling of interests" for accounting and financial reporting
purposes.

USE OF PROCEEDS

Assuming the Warrants are exercised in full, the Company will receive
aggregate proceeds in the amount of approximately $5,972,358, before deducting
estimated expenses of approximately $67,492. Any proceeds to the Company from
the issuance of any shares of Common Stock upon exercise of the Warrants will be
used by the Company for general corporate purposes. The Company will not receive
any proceeds from the conversion of Convertible Notes.


PLAN OF DISTRIBUTION

The shares of Common Stock offered hereby are issuable upon exercise of the
Warrants or upon conversion of the Convertible Notes. Set forth below is a
summary of certain terms of the Warrants and Convertible Notes relevant to such
exercise or conversion.

...

EXERCISE. Each class of Warrants provides that Warrants of such class may
be exercised in whole or in part (provided that Class C Warrants may be
exercised in part only in increments of 100 shares) at any time or from time to
time during the exercise period with respect thereto. The exercise may be
effected by the presentation and surrender of the Warrants at...

...

EXERCISE PRICES; EXPIRATION OF WARRANTS. The following table sets forth
with respect to each class of Warrants: (i) the exercise price per share of
PerSeptive Common Stock in effect prior to the Merger, (ii) the aggregate number
of shares of PerSeptive Common Stock into which all Warrants of such class were
exercisable prior to the Merger, (iii) the adjusted exercise price per share of
Common Stock which became effective as a result of the Merger, (iv) the
aggregate number of shares of Common Stock into which all Warrants of such class
became exercisable as a result of the Merger and (v) the expiration date with
respect to such class of Warrants.

EXERCISE TOTAL SHARES TOTAL SHARES
PRICE PER OF PERSEPTIVE ADJUSTED OF COMMON
SHARE OF COMMON STOCK EXERCISE PRICE STOCK ISSUABLE
PERSEPTIVE ISSUABLE PER SHARE OF FOLLOWING THE
CLASS OF WARRANTS COMMON STOCK BEFORE MERGER COMMON STOCK MERGER EXPIRATION DATE
-------------------------- ------------- -------------- -------------- -------------- ----------------------

Class C Warrants.......... $ 7.31 40,000 $ 37.95 7,704 March 15, 1999
Class E Warrants.......... 33.00 41,875 171.34 8,065 December 31, 1998
Class F Warrants.......... 7.62 100,000 39.56 19,260 October 1, 2002
Class G Warrants.......... 12.66 279,330 65.73 53,799 September 11, 2003



To: PuddleGlum who wrote (10)1/23/1998 3:26:00 PM
From: Don Dorsey  Read Replies (1) | Respond to of 122
 
Briefing.com keeps changing the earnings date. It now says 1-27. I guess we'll have to wait until next week.